Sign Up | Log In | What is SocialPicks?

BioElectronics Corp. (BIEL) Trade Now » Rate BIEL - Discuss BIEL - Add to Watch List

This is a micro-cap stock and may be a target of manipulation. Always do your research!

SocialPicks Sentiment:

** v.s. other stocks

This Quarter's Sentiment:

All:

66.0%

Top:

0.0%

Rate BIEL:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

BIEL Analysis & Videos »

... View All >

BIEL: Bull or Bear?

Bullish on BIEL ... BIEL

N/A

3.3%

Continue reading »

By atm3131 (+0.00% risk: conservative) 07/13/09

1 comment

Positive response to clinical Trials BIEL

N/A

<> <table width="100%"> <tbody> <tr> <td> Bioelectronics Corp Announces Results of Menstrual Pain Study
June 1, 2009 </td> </tr> <tr> <td>

Bioelectronics Corp announced the results of a randomized double-blind, placebo and positive controlled clinical trial of its Allay Menstrual Pain Relief product.

The clinical study, which involved 91 females with moderate to severe menstrual pain symptoms, demonstrated very high efficacy with no safety issues.

...

Continue reading »

By Corey Murphy (-10.04% risk: conservative) 06/27/09

Comment

BioElectronics Corp. BIEL

62%

BioElectronics Corporation (otc: BIEL)
BioElectronics Corporation (OTCPK: BIEL) is the maker of unique inexpensive, drug free, anti-inflammatory patches for a broad range of unmet soft tissue medical needs. The patches have an embedded microchip and battery that deliver pulsed electromagnetic energy, a clinically proven and widely accepted anti-inflammatory and pain relief therapy that, previously, has only been possible to obtain from large, facility-based equipment.

BioElectronics Corporation, a development stage company, develops and markets drug-...

Continue reading »

By Marian Filo (-24.55% risk: aggressive) 07/14/08

Comment

Drug free relief of edema and discomfort BIEL

N/A

BioElectronics Launches '1 Day Breast Augmentation Recovery Kit'
Thursday March 13, 7:15 am ET
Meets the Growing Demand for Quicker Surgical Recoveries

<> <>
FREDERICK, Md., March 13 /PRNewswire-FirstCall/ -- BioElectronics Corporation (BIEL) announces the product launch of its Breast Recovery Kit, for the relief of edema and post operative discomfort.
Developed by Dr. Barry Eppley, MD, DMD, the 1 Day Breast Recovery Kit allows breast surgery patients to return to their active lives the day after surgery. Using the patented technology, ActiPatch relieves edema and d...

Continue reading »

By Furry Sound (-17.62% risk: aggressive) 04/07/08

Comment

... View All >

People Bullish on BIEL

vaporpicks

Analyst

N/A

12 days ago

mbmalone

Analyst

N/A

24 days ago

rajerv

Analyst

N/A

about 1 mo ago

amahmood23

Analyst

N/A

about 1 mo ago

joope

Analyst

N/A

about 1 mo ago

People Bearish on BIEL

mulder

Analyst

N/A

25 days ago

Mike Havrilla

Principal

73%

26 days ago

tired_ant

Analyst

N/A

about 1 mo ago

noraa

Analyst

N/A

2 mos ago

scotyler12

Analyst

N/A

8 mos ago

... View All >

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.75%	378
2	Gerald Greene	18.14	+69.56%	208
3	stockmarketfunding.com	17.66	+25.70%	55
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+75.10%	38

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
MSFT	Microsoft Corp
PG	The Procter & Gamble Company
RIMM	Research in Motion Ltd
AAPL	Apple Computer Inc
AMD	Advanced Micro Devices Inc
YHOO	Yahoo! Inc

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

ABIO		BioMed News Bytes: Transcept, ProUroCare, SciClone, ABIO by Mike Havrilla
NVO		Diabetes Care: Global Investing Opportunities by Mike Havrilla
DNDN		BioMed News Bytes: CombinatoRx, Dendreon, Photocure, Pozen by Mike Havrilla
ONCY		Oncolytics Biotech Inc. down to 2,00 $ by Yannis Maarten
JNJ		Epinex Diagnostics: A New Paradigm for Diabetic Testing by Mike Havrilla

... more »

StreetInsider.com on BIEL

BioElectronics Technology More Effective Than Extra Strength Tylenol(R) in Reducing Muscle Soreness in Clinical Study

Trading Outlook for BioElectronics Corporation Issued by StockPreacher.com

Speculators Betting on BioElectronics' Upcoming Study Results

BioElectronics to Announce Results of Acetaminophen Comparison Study

BioElectronics Announces Financial Audit

Discussion Wall

+ Add

Be the first to start a discussion and earn 2 points.

... more »

More Resources

About BioElectronics Corp. - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.